Surgery partners’ chief HR officer sells $4,288 in stock

BRENTWOOD, Tenn.—Danielle Burkhalter, Chief Human Resources Officer at Surgery Partners, Inc. (NASDAQ:SGRY), recently sold 167 shares of the company’s common stock. The shares were sold at an average price of $25.68 each, amounting to a total transaction value of $4,288. The transaction comes as the $3.25 billion healthcare company’s stock shows strong momentum, with a 19.5% gain year-to-date, though InvestingPro analysis indicates the stock is currently trading near its Fair Value.

This sale was conducted to meet tax withholding obligations related to the vesting of restricted stock on January 31, 2025. Following the transaction, Burkhalter retains direct ownership of 30,187 shares of Surgery Partners. Analysts maintain a bullish outlook on the stock, with price targets ranging from $28 to $40. For deeper insights into insider trading patterns and comprehensive analysis, InvestingPro subscribers can access detailed research reports covering 1,400+ US stocks, including Surgery Partners.

In other recent news, Surgery Partners has seen significant developments. Cantor Fitzgerald maintained its Overweight rating on the company, observing a significant reduction in Ambulatory Surgery Center nursing openings, which could signal a potential transaction with Bain Capital. This speculation is further fueled by Bain Capital’s proposal to acquire Surgery Partners at $25.75 per share. The proposal is contingent upon approval from shareholders not affiliated with Bain Capital and a Special Committee of independent directors.

In addition to these potential changes, Surgery Partners has expanded its Board of Directors with the addition of Dr. Laura L. Forese, a healthcare veteran. Her extensive experience in healthcare administration is expected to contribute to Surgery Partners’ strategic growth. Meanwhile, BofA Securities upgraded its rating on Surgery Partners to Buy, citing strong industry tailwinds and a relatively low valuation as reasons for the upgrade.

These recent developments highlight Surgery Partners’ strategic maneuvers and efforts to enhance its leadership, while navigating potential transactions and industry challenges. The company’s operational efficiency, financial performance, and future direction continue to be closely monitored by investors and analysts alike.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.